EBP Compendium: Summary of Systematic Review
National Institute on Deafness and Other Communication Disorders, National Institutes of Health
Dependence of Hearing Changes on the Dose of Intratympanically Applied Gentamicin: A Meta-Analysis Using Mathematical Simulations of Clinical Drug Delivery Protocols
Salt, A. N., Gill, R. M., et al.
Laryngoscope, 118(10), 1793-1800.
Indicators of Review Quality:
The review addresses a clearly focused question
Criteria for inclusion of studies are provided
Search strategy is described in sufficient detail for replication
Included studies are assessed for study quality
Quality assessments are reproducible
Description: This is a meta-analysis of studies investigating safe dosages of intratympanic gentamicin that can be used in individuals being treated for Meniere's disease without resulting ototoxicicity.
Question not specifically stated.
Population: Not stated
Intervention/Assessment: Not applicable.
Number of Studies Included: 19
Years Included: Not further specified.
"...[T]here appears no logical rationale for rapidly repeated or continuous applications of gentamicin in the treatment of Meniere's disease." (p.1798)
Keywords: Ototoxicity, Hearing Loss
Access the Review
Added to Compendium: December 2011